Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -95.04M | $ -1.53 | 1 | 61.92M |
3/31/2025 | $ -94.25M | $ -1.54 | 1 | 61.05M |
12/31/2024 | $ -75.81M | $ -1.3 | 1 | 58.45M |
9/30/2024 | $ -53.53M | $ -0.88 | 1 | 60.72M |
6/30/2024 | $ -55.61M | $ -0.92 | 1 | 60.5M |
3/31/2024 | $ -54.27M | $ -1.06 | 1 | 51.29M |
12/31/2023 | $ -71.2M | $ -1.78 | 1 | 39.9M |
9/30/2023 | $ -92.12M | $ -2.23 | 1 | 41.33M |
6/30/2023 | $ -96.92M | $ -2.52 | 1 | 38.39M |
3/31/2023 | $ -106.8M | $ -3.02 | 1 | 35.35M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for PYXIS ONCOLOGY INC is calculated as follows: EBITDA [ $ -12.41M ] / (Shares WA [ 6.55M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.89 ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -11.29 |
max | $ 14.03 |
average | $ 2.03 |
median | $ 1 |
std | $ 4.28 |